1. Home
  2. CRDL vs ORGN Comparison

CRDL vs ORGN Comparison

Compare CRDL & ORGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRDL
  • ORGN
  • Stock Information
  • Founded
  • CRDL 2017
  • ORGN 2008
  • Country
  • CRDL Canada
  • ORGN United States
  • Employees
  • CRDL N/A
  • ORGN N/A
  • Industry
  • CRDL Biotechnology: Biological Products (No Diagnostic Substances)
  • ORGN Major Chemicals
  • Sector
  • CRDL Health Care
  • ORGN Industrials
  • Exchange
  • CRDL Nasdaq
  • ORGN Nasdaq
  • Market Cap
  • CRDL 126.5M
  • ORGN 131.4M
  • IPO Year
  • CRDL N/A
  • ORGN N/A
  • Fundamental
  • Price
  • CRDL $1.05
  • ORGN $0.53
  • Analyst Decision
  • CRDL Strong Buy
  • ORGN
  • Analyst Count
  • CRDL 2
  • ORGN 0
  • Target Price
  • CRDL $9.00
  • ORGN N/A
  • AVG Volume (30 Days)
  • CRDL 1.2M
  • ORGN 1.4M
  • Earning Date
  • CRDL 08-14-2025
  • ORGN 08-14-2025
  • Dividend Yield
  • CRDL N/A
  • ORGN N/A
  • EPS Growth
  • CRDL N/A
  • ORGN N/A
  • EPS
  • CRDL N/A
  • ORGN N/A
  • Revenue
  • CRDL N/A
  • ORGN $28,667,000.00
  • Revenue This Year
  • CRDL N/A
  • ORGN $49.18
  • Revenue Next Year
  • CRDL N/A
  • ORGN $144.81
  • P/E Ratio
  • CRDL N/A
  • ORGN N/A
  • Revenue Growth
  • CRDL N/A
  • ORGN N/A
  • 52 Week Low
  • CRDL $0.77
  • ORGN $0.40
  • 52 Week High
  • CRDL $2.63
  • ORGN $1.90
  • Technical
  • Relative Strength Index (RSI)
  • CRDL 39.49
  • ORGN 39.15
  • Support Level
  • CRDL $1.12
  • ORGN $0.51
  • Resistance Level
  • CRDL $1.14
  • ORGN $0.56
  • Average True Range (ATR)
  • CRDL 0.07
  • ORGN 0.03
  • MACD
  • CRDL -0.00
  • ORGN -0.01
  • Stochastic Oscillator
  • CRDL 5.56
  • ORGN 28.91

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

About ORGN Origin Materials Inc.

Origin Materials Inc is a carbon-negative materials company. The platform turns the carbon found in biomass into useful materials, while eliminating the need for fossil resources and capturing carbon in the process. Its products include, PET circular caps and closures, Para-xylene, carbon black, Levulinic acid among others by using materials like food and beverage packaging, clothing, textiles, plastics, car parts, carpeting, tires, adhesives, soil amendments, and fuels.

Share on Social Networks: